Cartesian Therapeutics (RNAC) Other financing activities (2015 - 2025)
Cartesian Therapeutics (RNAC) reported Other financing activities of $102000.0 for Q4 2025, up 54.55% year-over-year from $66000.0 in Q4 2024, and up 137.21% quarter-over-quarter from $43000.0 in Q3 2025.
Cartesian Therapeutics (RNAC) Other financing activities (2015 - 2025) Analysis & Trends
Cartesian Therapeutics (RNAC) has 6 years of Other financing activities data on file, last reported at $102000.0 in Q4 2025.
- Other financing activities for Q4 2025 came in at $102000.0, up 54.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $170000.0 (down 67.31% YoY), and the FY2025 annual result was $624000.0, up 845.45% from the prior year.
- Other financing activities improved to $102000.0 in Q4 2025 per RNAC's latest filing, from $43000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $454000.0 in Q1 2025 and troughed at $25000.0 in Q2 2025.
- A 3-year average of $133333.3 and a median of $84000.0 in 2024 frame the typical range for Other financing activities.
- On a YoY basis, Other financing activities climbed as much as 54.55% in 2025 and fell as far as 54.55% in 2025.
- A 3-year view of Other financing activities shows it stood at $110000.0 in 2022, then plunged by 40.0% to $66000.0 in 2024, then jumped by 54.55% to $102000.0 in 2025.
- Business Quant data shows RNAC's Other financing activities at $102000.0 in Q4 2025, $43000.0 in Q3 2025, and $25000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 102,000.00 |
| Dec 31, 2025 | 102,000.00 |
| Sep 30, 2025 | 43,000.00 |
| Sep 30, 2025 | 43,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 454,000.00 |
| Mar 31, 2025 | 454,000.00 |
| Dec 31, 2024 | 66,000.00 |
| Dec 31, 2024 | 66,000.00 |
| Mar 31, 2022 | 110,000.00 |
| Mar 31, 2022 | 110,000.00 |
| Dec 31, 2020 | -151,000.00 |
| Dec 31, 2020 | -151,000.00 |
| Sep 30, 2020 | -45,000.00 |
| Sep 30, 2020 | -45,000.00 |
| Jun 30, 2020 | -4.53 Mn |
| Jun 30, 2020 | -4.53 Mn |
| Mar 31, 2020 | 4.38 Mn |
| Mar 31, 2020 | 4.38 Mn |